Intranasal Vasopressin Treatment in Children With Autism

Trial Profile

Intranasal Vasopressin Treatment in Children With Autism

Phase of Trial: Phase II

Latest Information Update: 23 May 2018

At a glance

  • Drugs Vasopressin (Primary)
  • Indications Pervasive child development disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Feb 2018 Status changed from not yet recruiting to recruiting.
    • 20 Sep 2017 Planned initiation date changed from 1 Jul 2017 to 1 Oct 2017.
    • 05 Jul 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top